Change region

You appear to be in the US - would you like to view our US website

Contact Search

The evolving bone and joint supplement market

It has been reported by Modor Intelligence that the global bone and joint supplement market is projected to grow at a CAGR of 6.3% between 2019-2024. The drive of this market is due to the growing baby boomer population in addition to gym goers and athletes who are seeking natural solutions to support their joints through intense exercise.

Healthy ageing

The ability to move around and maintain mobility is one of the top priorities for the ageing population. Innova Market Insights reports that 30% of people aged between 44-54 years suffer from osteoarthritis, 50% of people over 65 and 80% of those aged 75 and over suffer with osteoarthritis.

The ageing population is looking for more natural and sustainable ingredients in their functional foods and supplements.

An evolving market

Consumer’s knowledge is growing, and many have recognised the importance of taking care of their joints at an early age through supplementation. Gym goers and athletes are taking these steps to care for their joints so they can stay physically active and maintain peak performance.

The joint care market is also moving to a wider concept to total health including all aspects of mobility-related health. This includes products for tendon and muscle health. Younger consumers are looking for products that can be easily incorporated into their routines in product applications such as gummies, sprays as well as functional foods and beverages.

UC-II® for joint mobility and comfort

UC-II® supplies a patented form of undenatured type II collagen for joint health that helps to slow down the degradation of type II collagen in the joints. It is made from chicken sternum cartilage using a patented manufacturing method that ensures a minim level of 3% of undenatured type II collagen as well as its biological activity.

UC-II® is supported by a published clinical research study conducted in healthy subjects who experienced joint discomfort with physical activity. The participants had no prior history of arthritic disease. The results of the study showed that 40mg of UC-II® once a day led to improved knee joint extension in healthy subjects*.

UC-II® is suitable for a variety of applications including tablets, capsules, food and beverages.

Click here for more information on UC-II®.



*Lugo, James P et al. “Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers.” Journal of the International Society of Sports Nutrition vol. 10,1 48. 24 Oct. 2013, doi:10.1186/1550-2783-10-48



We have detected that you are visiting from the US.

Please choose which of our websites you would like to visit?